Our Early Cognitive Decline program is built on principles from the ReCODE and Bredesen protocols, focusing on identifying and addressing the root causes of brain dysfunction. We evaluate contributors such as inflammation, metabolic health, toxins, and vascular factors through a functional interpretation of advanced bloodwork and diagnostics. By leveraging cutting-edge technology and a proactive, personalized approach, we aim to support cognitive resilience, optimize brain performance, and slow or reverse early decline.